1,695
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Talin1 regulates glucose metabolism and endometrial receptivity via GLUT-4 in patients with polycystic ovary syndrome and insulin resistance

, , , , , , , & show all
Article: 2231085 | Received 27 Feb 2023, Accepted 26 Jun 2023, Published online: 03 Jul 2023

References

  • Kovacs G, Clarke S, Burger H, et al. Surgical or medical treatment of polycystic ovary syndrome: a cost-benefit analysis. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2002;16(1):1–7.
  • Palomba S, Piltonen TT, Giudice LC. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update. 2021;27(3):584–618.
  • Johnson JE, Daley D, Tarta C, et al. Risk of endometrial cancer in patients with polycystic ovarian syndrome: a meta‑analysis. Oncol Lett. 2023;25(4):168.
  • Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030. doi: 10.1210/er.2011-1034.
  • Goodarzi M, Korenman S. The importance of insulin resistance in polycystic ovary syndrome. Fertil Steril. 2003;80(2):255–258. doi: 10.1016/s0015-0282(03)00734-9.
  • Gough RE, Goult BA-O. The tale of two talins - two isoforms to fine-tune integrin signalling. FEBS Lett. 2018;592(12):2108–2125.
  • Desiniotis A, Kyprianou N. Significance of talin in cancer progression and metastasis. Int Rev Cell Mol Biol. 2011;289:117–147. doi: 10.1016/B978-0-12-386039-2.00004-3.
  • Shen Y, Qin A. Regulation of embryonic signal on Talin1 in mouse endometrium. Reprod Sci. 2019;26(9):1277–1286. doi: 10.1177/1933719118815584.
  • Liu J, He X, Qi Y, et al. Talin1 regulates integrin turnover to promote embryonic epithelial morphogenesis. Mol Cell Biol. 2011;31(16):3366–3377. doi: 10.1128/MCB.01403-10.
  • von Wolff M, Ursel S, Hahn U, et al. Glucose transporter proteins (GLUT) in human endometrium: expression, regulation, and function throughout the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab. 2003;88(8):3885–3892. doi: 10.1210/jc.2002-021890.
  • Medina R, Meneses A, Vera J, et al. Differential regulation of glucose transporter expression by estrogen and progesterone in Ishikawa endometrial cancer cells. J Endocrinol. 2004;182(3):467–478. doi: 10.1677/joe.0.1820467.
  • Li J, Lin J, Yang Y, et al. Talin1 regulates the endometrial epithelial cell adhesive capacity by interacting with LASP1 and vitronectin. Reprod Biol. 2020;20(2):229–236. doi: 10.1016/j.repbio.2020.02.006.
  • Chen S, Liu B, Li J, et al. Talin1 regulates endometrial adhesive capacity through the ras signaling pathway. Life Sci. 2021;274:119332. doi: 10.1016/j.lfs.2021.119332.
  • Yang Y, Chen X, Saravelos SH, et al. HOXA-10 and E-cadherin expression in the endometrium of women with recurrent implantation failure and recurrent miscarriage. Fertil Steril. 2017;107(1):136–143.e2. doi: 10.1016/j.fertnstert.2016.09.016.
  • Revised 2003. Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.
  • Dumesic DA, Lobo RA. Cancer risk and PCOS. Steroids. 2013;78(8):782–5.
  • Shafiee MN, Chapman C, Fau- Barrett D, et al. Reviewing the molecular mechanisms which increase endometrial cancer (EC) risk in women with polycystic ovarian syndrome (PCOS): time for paradigm shift? Gynecol Oncol. 2013;131(2):489–192.
  • Joham AE, Norman RJ, Stener-Victorin E, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10(9):668–680. doi: 10.1016/S2213-8587(22)00163-2.
  • Barry JA, Azizia MM, Hardiman PJ. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(5):748–758.
  • Dumesic DA, Abbott DH, Sanchita S, et al. Endocrine-Metabolic dysfunction in polycystic ovary syndrome: an evolutionary perspective. Curr Opin Endocr Metab Res. 2020;12:41–48.
  • Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030.
  • Palomba S, de Wilde MA, Falbo A, et al. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015;21(5):575–592.
  • Palomba S, Russo T, Fau- Falbo A, et al. Macroscopic and microscopic findings of the placenta in women with polycystic ovary syndrome. Hum Reprod. 2013;28(10):2838–2847.
  • Palomba S, Russo T, Fau- Falbo A, et al. Decidual endovascular trophoblast invasion in women with polycystic ovary syndrome: an experimental case-control study. J Clin Endocrinol Metab. 2012;97(7):2441–2449.
  • Haydari Z, Shams H, Jahed Z, et al. Kindlin assists talin to promote integrin activation. Biophys J. 2020;118(8):1977–1991. doi: 10.1016/j.bpj.2020.02.023.
  • Wang YY, Duan H, Wang S, et al. Talin1 induces Epithelial-Mesenchymal transition to facilitate endometrial cell migration and invasion in adenomyosis under the regulation of microRNA-145-5p. Reprod Sci. 2021;28(5):1523–1539. doi: 10.1007/s43032-020-00444-8.
  • Wang YY, Duan H, Wang S, et al. Upregulated Talin1 synergistically boosts β-estradiol-induced proliferation and pro-angiogenesis of eutopic and ectopic endometrial stromal cells in adenomyosis. Reprod Biol Endocrinol. 2021;19(1):70. doi: 10.1186/s12958-021-00756-7.
  • Qiu P, Lin X, Deng G. [Talin1 is highly expressed in the fallopian tube and chorionic villi to promote trophoblast invasion in tubal pregnancy]. Nan Fang Yi Ke Da Xue Xue Bao. 2022;42(4):610–617.
  • Dedden D, Schumacher S, Kelley CF, et al. The architecture of Talin1 reveals an autoinhibition mechanism. Cell. 2019;179(1):120–131.e13. doi: 10.1016/j.cell.2019.08.034.
  • Zhai J, Liu CX, Tian ZR, et al. Effects of metformin on the expression of GLUT4 in endometrium of obese women with polycystic ovary syndrome. Biol Reprod. 2012;87(2):29.
  • Schulte MM, Tsai JH, Moley KH. Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation. Reprod Sci. 2015;22(1):6–14. doi: 10.1177/1933719114561552.
  • Alam F, Islam MA, Khalil MI, et al. Metabolic control of type 2 diabetes by targeting the GLUT4 glucose transporter: intervention approaches. Curr Pharm Des. 2016;22(20):3034–3049. doi: 10.2174/1381612822666160307145801.
  • Ujvari D, Hulchiy M, Calaby A, et al. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome. Hum Reprod. 2014;29(7):1526–1535. doi: 10.1093/humrep/deu114.
  • Ormazabal P, Romero C, Quest A, et al. Testosterone modulates the expression of molecules linked to insulin action and glucose uptake in endometrial cells. Horm Metab Res. 2013;45(9):640–645. doi: 10.1055/s-0033-1345176.
  • Fornes R, Ormazabal P, Rosas C, et al. Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia. Mol Med. 2010;16(3–4):129–136. doi: 10.2119/molmed.2009.00118.
  • Mioni R, Chiarelli S, Xamin N, et al. Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients. J Clin Endocrinol Metab. 2004;89(8):4089–4096. doi: 10.1210/jc.2003-032028.
  • Mozzanega B, Mioni R, Granzotto M, et al. Obesity reduces the expression of GLUT4 in the endometrium of normoinsulinemic women affected by the polycystic ovary syndrome. Ann N Y Acad Sci. 2004;1034:364–374. doi: 10.1196/annals.1335.038.
  • Long Y, Wang YC, Yuan DZ, et al. GLUT4 in mouse endometrial epithelium: roles in embryonic development and implantation. Front Physiol. 2021;12:674924. doi: 10.3389/fphys.2021.674924.